跳至主要内容
临床试验/CTRI/2022/03/041296
CTRI/2022/03/041296尚未招募不适用

A clinical study for evaluating effectiveness of individualised homoeopathic medicine in the treatment of vitiligo

Dr Neha Singhal1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2022年3月28日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
30
试验地点
1
主要终点
Size of skin lesion.

研究概览

简要总结

This study is an open label, prospective, uncontrolled clinical trial for evaluating the effectiveness of individualised homoeopathic medicine in the treatment of vitiligo. The homoeopathic medicine will be administered in centesimal scale, each dose shall consist of 6-8 globules of cane sugar, moistened with the indicated medicine to be taken orally on clean tongue; dosage and repetition depending upon the individual requirement of the cases. All medicines will be procured from a Good Manufacturing Practice (GMP) certified firm. The outcomes will be assessed initially at the baseline and every month upto 1 year.

研究设计

研究类型
Interventional
分配方式
Not Applicable
盲法
Not Applicable

入排标准

年龄范围
5.00 Year(s) 至 65.00 Year(s)(—)
性别
All

入选标准

  • Patients suffering from vitiligo.

排除标准

  • Cases with other auto-immune disorders.

结局指标

主要结局

Size of skin lesion.

时间窗: Intially at the baseline then every month upto 1 year.

次要结局

  • VASI score.
  • VitiQol questionnaire.(Initially at the baseline then every month upto 1 year.)
  • Skindex-16 questionnaire.(Initially at the baseline then every month upto 1 year.)
  • DLQI questionnaire.(Initially at the baseline then every month upto 1 year.)

研究者

发起方
Dr Neha Singhal
申办方类型
Other [Junior resident]

研究点 (1)

Loading locations...

相似试验